This paper provides a review and evaluation of the published evidence relating to the efficacy, safety and ease of administration of the rapid-acting insulin analogue insulin aspart in comparison ...

They were eligible if their physician believed that they required insulin therapy and had decided to start treatment with, or switch treatment to, BIAsp 30. Thus, patients could be treatment-naive ...